Company Profile
ResMed Stock Price, News & Analysis
- Ticker:
- RMD
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Stock performance
223.24 USD (-0.35%)
Close
Last updated: August 6, 2026
26.5B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, RMD closed down 0.35% at $223.24. No new same-company headline was identified in the current news window.
Company overview
Business overview
ResMed is a medical device and digital health company focused on sleep apnea, respiratory care, and related connected-health solutions. Its business is built around device usage, recurring supplies, and software-enabled care delivery.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, ResMed has a global healthcare footprint. It sits in medtech and digital health rather than therapeutic biotech.
Business Model Characteristics
The company generates revenue from PAP devices, masks, accessories, and connected-care services. Investors watch device adoption, sleep market demand, and the balance between recurring supplies and new product growth.
Position Within the Biotechnology Landscape
ResMed is outside biotech but important in healthcare technology because of its recurring device model. It moves on procedure and chronic-care demand rather than on clinical-trial catalysts.
Future catalysts
ResMed’s catalysts are sleep-apnea device growth, GLP-1-driven OSA awareness, and continued software / patient-care platform expansion. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ResMed (RMD)?
ResMed (RMD) most recently closed at 223.24 USD, a -0.35% move versus the previous session.
What is the market cap of ResMed (RMD)?
ResMed currently has a market capitalization of 26.5B USD on BioPharmSignal.
What does ResMed do?
ResMed is a medical device and digital health company focused on sleep apnea, respiratory care, and related connected-health solutions. Its business is built around device usage, recurring supplies, and software-enabled care delivery.
On which exchange is RMD stock listed?
ResMed (RMD) is associated with NYSE, United States, MedTech.
What is GLP-1?
ResMed’s catalysts are sleep-apnea device growth, GLP-1-driven OSA awareness, and continued software / patient-care platform expansion.
Which conditions is ResMed targeting with GLP-1?
ResMed is associated with respiratory disease based on its company overview and current catalyst commentary.
How does ResMed describe recent progress with GLP-1?
ResMed’s catalysts are sleep-apnea device growth, GLP-1-driven OSA awareness, and continued software / patient-care platform expansion.
What is ResMed?
ResMed is a medical device and digital health company focused on sleep apnea, respiratory care, and related connected-health solutions.